Cargando…

COVID-19–associated Pulmonary Aspergillosis

Detalles Bibliográficos
Autores principales:	van Arkel, Andreas L. E., Rijpstra, Tom A., Belderbos, Huub N. A., van Wijngaarden, Peter, Verweij, Paul E., Bentvelsen, Robbert G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328331/ https://www.ncbi.nlm.nih.gov/pubmed/32396381 http://dx.doi.org/10.1164/rccm.202004-1038LE

Ejemplares similares

Reply to Fekkar et al.: Fungal Infection during COVID-19: Does Aspergillus Mean Secondary Invasive Aspergillosis?
por: Bentvelsen, Robbert G., et al.
Publicado: (2020)

Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave
por: Bentvelsen, Robbert G., et al.
Publicado: (2022)

Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis – Authors' reply
por: Koehler, Philipp, et al.
Publicado: (2021)

Influenza Coinfection: Be(a)ware of Invasive Aspergillosis
por: Verweij, Paul E, et al.
Publicado: (2020)

Detection of Invasive Pulmonary Aspergillosis in COVID-19 with Nondirected BAL
por: Van Biesen, Stefaan, et al.
Publicado: (2020)

Surveillance for COVID-19-associated pulmonary aspergillosis
por: Brown, Li-An K, et al.
Publicado: (2020)

Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis
por: Permpalung, Nitipong, et al.
Publicado: (2021)

Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis
por: Jabeen, Kauser, et al.
Publicado: (2021)

Diagnosing COVID-19-associated pulmonary aspergillosis
por: Verweij, Paul E, et al.
Publicado: (2020)

COVID-19-associated invasive pulmonary aspergillosis: high incidence or difficult diagnosis?
por: Rouzé, Anahita, et al.
Publicado: (2021)

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges
por: Prattes, Juergen, et al.
Publicado: (2021)

Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis
por: de Brabander, Justin, et al.
Publicado: (2022)

Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis – Authors' reply
por: Gangneux, Jean-Pierre, et al.
Publicado: (2022)

COVID-19-associated pulmonary aspergillosis (CAPA) might be associated with increased risk for pneumopleural fistula
por: Naendrup, Jan-Hendrik, et al.
Publicado: (2023)

COVID-19 associated with concomitant mucormycosis and aspergillosis
por: Lai, Chih-Cheng, et al.
Publicado: (2022)

Does Pulmonary Aspergillosis Complicate Coronavirus Disease 2019?
por: Beer, Karlyn D., et al.
Publicado: (2020)

Integrated Therapy for Invasive Pulmonary Aspergillosis in a Patient with Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome
por: Shi, Ya-Qin, et al.
Publicado: (2015)

COVID-19-associated invasive pulmonary aspergillosis
por: Rutsaert, Lynn, et al.
Publicado: (2020)

Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis
por: Armstrong-James, Darius, et al.
Publicado: (2020)

Ultrasound-guided Transthoracic Needle Aspiration to Diagnose Invasive Pulmonary Aspergillosis
por: Keng, Li-Ta, et al.
Publicado: (2020)

Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis
por: Janssen, Nico A.F., et al.
Publicado: (2021)

Fungal Infection during COVID-19: Does Aspergillus Mean Secondary Invasive Aspergillosis?
por: Fekkar, Arnaud, et al.
Publicado: (2020)

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
por: Verweij, Paul E., et al.
Publicado: (2021)

COVID‐19 associated pulmonary aspergillosis
por: Koehler, Philipp, et al.
Publicado: (2020)

Fungal infections should be part of the core outcome set for COVID-19
por: Verweij, Paul E, et al.
Publicado: (2021)

Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients
por: Ergün, Mehmet, et al.
Publicado: (2021)

Pulmonary aspergillosis, mucormycosis, and actinomycosis co-infection presenting as a cavitary lesion in a patient with diabetes
por: Lin, Lan, et al.
Publicado: (2019)

Aspergillosis in the ICU: Hidden Enemy or Bogeyman?
por: Aberegg, Scott K., et al.
Publicado: (2021)

Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy
por: van Grootveld, Rebecca, et al.
Publicado: (2023)

COVID-19 associated pulmonary aspergillosis
por: Álvarez Fernández, M., et al.
Publicado: (2023)

A mysterious surge of aspergillosis among non-SARS-CoV-2 patients during COVID-19 pandemic
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

Pulmonary edema in COVID-19: Explained by bradykinin?
por: Zwaveling, Suzanne, et al.
Publicado: (2020)

Covid-19-Associated Pulmonary Aspergillosis: The Other Side of the Coin
por: Costantini, Claudio, et al.
Publicado: (2020)

Reply to Aberegg and Wolfe: Aspergillosis in the ICU: Hidden Enemy or Bogeyman?
por: Loughlin, Laura, et al.
Publicado: (2021)

Performance of the bronchoalveolar lavage fluid later-flow device test in the rapid diagnosis of non-neutropenic invasive pulmonary aspergillosis
por: Liu, Lu-Lu, et al.
Publicado: (2020)

CT findings of COVID-19-associated pulmonary aspergillosis: a systematic review and individual patient data analysis
por: Hong, Wonju, et al.
Publicado: (2022)

Commentary: Human Immunodeficiency Virus and Allergic Bronchopulmonary Aspergillosis
por: Delfino, Emanuele, et al.
Publicado: (2016)

Clinical Characteristics of Fifty Patients with Allergic Bronchopulmonary Aspergillosis
por: Zou, Min-Fang, et al.
Publicado: (2018)

Covid-19 and in situ pulmonary artery thrombosis
por: Mandal, Amit K.J., et al.
Publicado: (2021)

Nebulized Amphotericin B in Mechanically Ventilated COVID-19 Patients to Prevent Invasive Pulmonary Aspergillosis: A Retrospective Cohort Study
por: Melchers, Max, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3k1rsrc525g09c7icsmptuqs12